Clin2
NCT07471256Possibly a fitNot yet recruiting

Treating lobar brain hemorrhage with a small tube and clot-busting medicine

Intracerebral Hemorrhage Lobar

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests a new way to remove brain blood clots using a small tube and a clot-busting medicine (tenecteplase). It aims to help people recover better after a specific type of bleeding in the brain.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
636 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 79 years old
  • You had bleeding in the outer part of the brain, not deep in the center
  • Your symptoms started within the last 24 hours
  • You are able to follow commands and are not in a coma
  • You have not been taking blood-thinning medications before the bleeding
  • You are willing to have a small surgical procedure to remove the blood clot

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07697742Not yet recruiting
Surgery to remove surface brain bleeds using microsurgery

This study tests a special type of brain surgery to remove blood from a bleed near the surface of the brain. The goal is to see if using a precise, minimally invasive technique can improve recovery compared to standard care.

Calgary, Alberta
NCT06921616Not yet recruiting· Phase 4
Early surgery plus steroid medicine for brain bleeds

This trial tests whether removing the brain bleed with a small camera-guided surgery and giving a steroid medicine early can help people recover better. It is for people who have had a bleed in the outer part of the brain within the last day.

Luzhou, China
NCT06868511Recruiting· Phase 3
Minimally invasive clot removal with tenecteplase for deep brain bleed

This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.

Beijing, China
NCT06814964Recruiting· Phase 1
Intraventricular clot removal with medication after brain bleed

This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.

Beijing, Beijing Municipality
NCT06688162Enrolling by invitation
Minimally invasive surgery for small brain bleeds

This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.

Beijing
NCT07208097Recruiting
Brain bleed clot dissolving with tNK for stroke recovery

This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.

Suzhou, Anhui

Hear when a new Intracerebral Hemorrhage Lobar trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.